Back to Results
First PageMeta Content
Novo Nordisk / Technology / Pharmaceutical industry / Business / BB Biotech / Pharmaceutical industry in India / Vertex Pharmaceuticals


Media release as of April 17, 2015 Interim report of BB Biotech AG as of March 31, 2015 Biotech sector continues to outperform – strengthened balance sheets will sustain the industry’s solid growth
Add to Reading List

Document Date: 2015-04-16 10:43:32


Open Document

File Size: 63,48 KB

Share Result on Facebook

Company

Theravance / Merck & Co Inc / Radius / Synageva / AbbVie / Gilead / Bacterial Pneumonia / Isis Pharmaceuticals / Pharmacyclics / Alnylam Pharmaceuticals / Cempra / Celgene / Alexion Pharmaceuticals / Tesaro / Media Relations Bellevue Asset Management AG / Incyte / Achillion / Infinity Pharmaceuticals / Medivation / Claude Mikkelsen / Vertex Pharmaceuticals / Halozyme Therapeutics / Actelion / Intercept / Tetraphase / Neurocrine Biosciences / Sanofi / Vertex / BB Biotech AG / Immunogen / Novo Nordisk / Novavax / Regeneron Pharmaceuticals / Investor Relations Bellevue Asset Management AG / Thomas Egger / /

Country

Switzerland / Germany / Italy / Japan / United States / /

Currency

CHF / USD / /

/

Event

FDA Phase / Security Buyback / General or Shareholder Meeting / M&A / Dividend Issuance / /

IndustryTerm

biotechnology / chronic weight management / biotechnology investors / healthcare industry / biotechnology industry / bank actions / differentiated products / treatment of cystic fibrosis / treatment of chronic liver diseases / /

MarketIndex

S&P 500 / Nasdaq Biotech / /

MedicalCondition

Community Acquired Bacterial Pneumonia / Ryzodeg diabetes / congenital adrenal hyperplasia / hepatitis C / non-small cell lung cancer / cystic fibrosis / chronic weight management / non-alcoholic fatty liver disease / diabetes / chronic liver diseases / orphan disease primary biliary cirrhosis / /

MedicalTreatment

statin therapy / /

NaturalFeature

FLINT / /

OperatingSystem

Isis / /

Organization

European Central Bank / Swiss National Bank / FDA / /

Person

Maria-Grazia Iten-Alderuccio / Tanja Chicherio / Silvia Schanz / /

/

Product

Gilead Actelion 10.7% 9.5 / Saxenda / /

Technology

alpha / biotechnology / /

URL

www.bbbiotech.com / /

SocialTag